BACKGROUND: Coinfection of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is a substantial medical and public health concern due to its increasing prevalence and complex patient management. Alcohol use may worsen HCV-related liver disease and interfere with adherence to antiretroviral therapy (ART) and medical care. We therefore studied the association between HCV infection and markers of HIV disease progression in adults with alcohol problems. METHODS: This is a longitudinal study of 396 HIV-infected persons with alcohol problems, 199 (50%) of whom were coinfected with HCV (positive HCV RNA test). CD4 cell counts and HIV RNA levels were assessed at baseline and then every 6 months for up to 42 months. Hepatitis C virus RNA status was determined at study enrollment. We examined the relationship between HCV infection and laboratory markers of HIV progression (CD4 cell count and log10 HIV RNA) by fitting multivariable longitudinal regression models for each outcome. RESULTS: Among subjects who were adherent to ART, the presence of HCV infection was associated with a lower CD4 cell count (adjusted mean difference -46.0 cells/microL, p=0.03). There was no association observed between HCV infection and CD4 cell count among those not adherent to ART or those not taking ART. No significant association was observed between HCV infection and HIV RNA regardless of ART status. CONCLUSIONS: Hepatitis C virus infection has an adverse effect on CD4 cell count in patients with alcohol problems who are adherent to ART. Addressing HCV coinfection among these patients may confer additional immunologic benefit for this patient population.
BACKGROUND: Coinfection of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is a substantial medical and public health concern due to its increasing prevalence and complex patient management. Alcohol use may worsen HCV-related liver disease and interfere with adherence to antiretroviral therapy (ART) and medical care. We therefore studied the association between HCV infection and markers of HIV disease progression in adults with alcohol problems. METHODS: This is a longitudinal study of 396 HIV-infectedpersons with alcohol problems, 199 (50%) of whom were coinfected with HCV (positive HCV RNA test). CD4 cell counts and HIV RNA levels were assessed at baseline and then every 6 months for up to 42 months. Hepatitis C virus RNA status was determined at study enrollment. We examined the relationship between HCV infection and laboratory markers of HIV progression (CD4 cell count and log10 HIV RNA) by fitting multivariable longitudinal regression models for each outcome. RESULTS: Among subjects who were adherent to ART, the presence of HCV infection was associated with a lower CD4 cell count (adjusted mean difference -46.0 cells/microL, p=0.03). There was no association observed between HCV infection and CD4 cell count among those not adherent to ART or those not taking ART. No significant association was observed between HCV infection and HIV RNA regardless of ART status. CONCLUSIONS:Hepatitis C virus infection has an adverse effect on CD4 cell count in patients with alcohol problems who are adherent to ART. Addressing HCV coinfection among these patients may confer additional immunologic benefit for this patient population.
Authors: P Baré; I Massud; L Belmonte; M Corti; M Villafañe; R Pérez Bianco; M de Tezanos-pinto; M M E de Bracco; B Ruibal-Ares Journal: Haemophilia Date: 2003-09 Impact factor: 4.287
Authors: M Quintana; J del Amo; A Barrasa; S Pérez-Hoyos; I Ferreros; F Hernández; A Villar; V Jiménez; F Bolúmar Journal: Haemophilia Date: 2003-09 Impact factor: 4.287
Authors: Gilbert R Kaufmann; Luc Perrin; Guiseppe Pantaleo; Milos Opravil; Hansjakob Furrer; Amalio Telenti; Bernard Hirschel; Bruno Ledergerber; Pietro Vernazza; Enos Bernasconi; Martin Rickenbach; Matthias Egger; Manuel Battegay Journal: Arch Intern Med Date: 2003-10-13
Authors: Christian Jaggy; Jan von Overbeck; Bruno Ledergerber; Claude Schwarz; Matthias Egger; Martin Rickenbach; Hans-Jakob Furrer; Amalio Telenti; Manuel Battegay; Markus Flepp; Pietro Vernazza; Enos Bernasconi; Bernard Hirschel Journal: Lancet Date: 2003-09-13 Impact factor: 79.321
Authors: Jeffrey H Samet; Sharon J Phillips; Nicholas J Horton; Elizabeth T Traphagen; Kenneth A Freedberg Journal: AIDS Res Hum Retroviruses Date: 2004-02 Impact factor: 2.205
Authors: W Phillip Law; Chris J Duncombe; Apicha Mahanontharit; Mark A Boyd; Kiat Ruxrungtham; Joep M A Lange; Praphan Phanuphak; David A Cooper; Gregory J Dore Journal: AIDS Date: 2004-05-21 Impact factor: 4.177
Authors: Heidi M Crane; Mary E McCaul; Geetanjali Chander; Heidi Hutton; Robin M Nance; Joseph A C Delaney; Joseph O Merrill; Bryan Lau; Kenneth H Mayer; Michael J Mugavero; Matthew Mimiaga; James H Willig; Greer A Burkholder; Daniel R Drozd; Rob J Fredericksen; Karen Cropsey; Richard D Moore; Jane M Simoni; W Christopher Mathews; Joseph J Eron; Sonia Napravnik; Katerina Christopoulos; Elvin Geng; Michael S Saag; Mari M Kitahata Journal: AIDS Behav Date: 2017-07
Authors: Nicholas Petersdorf; Jennifer M Ross; Helen A Weiss; Ruanne V Barnabas; Judith N Wasserheit Journal: J Int AIDS Soc Date: 2016-09-19 Impact factor: 5.396
Authors: Vlada V Melekhin; Bryan E Shepherd; Samuel E Stinnette; Peter F Rebeiro; Gema Barkanic; Stephen P Raffanti; Timothy R Sterling Journal: PLoS One Date: 2009-09-09 Impact factor: 3.240